Skip to main content
You're browsing a read-only preview with shortened excerpts. Unlock full access

News preview

PathMaker Reports Non-Invasive Stimulation Cut Toxic TDP-43 Aggregates 76% in ALS Mouse Model

GlobeNewswire · October 6, 2026

Preview

PathMaker Neurosystems, a clinical-stage ALS neurotechnology company, announced a peer-reviewed paper in Neuromodulation, the journal of the International Neuromodulation Society, reporting that its non-invasive Multi-Site DCS technology, which delivers…

The complete summary, “why it matters” analysis and the original source link are available to members.

NeuromodulationNeurostimulation